4//SEC Filing
KV PHARMACEUTICAL CO /DE/ 4
Accession 0001260836-13-000001
CIK 0000057055operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 1:52 PM ET
Size
13.9 KB
Accession
0001260836-13-000001
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA/KVB
LEHRER JOSEPH D
Director
Transactions
- Other
Option to Purchase
2013-09-16−10,000→ 0 totalExercise: $1.62Exp: 2020-09-07→ Class A Common Stock (10,000 underlying) - Other
Option to Purchase
2013-09-16−30,000→ 0 totalExercise: $0.94Exp: 2022-05-14→ Class A Common Stock (30,000 underlying) - Other
Class B Common Stock
2013-09-16−100→ 0 total - Other
Option to Purchase
2013-09-16−7,500→ 0 totalExercise: $1.11Exp: 2020-06-10→ Class A Common Stock (7,500 underlying) - Other
Option to Purchase
2013-09-16−30,000→ 0 totalExercise: $1.49Exp: 2021-09-08→ Class A Common Stock (30,000 underlying)
Footnotes (5)
- [F1]On September 16, 2013, the Sixth Amended Joint Chapter 11 Plan of Reorganization of K-V Pharmaceutical Company (the "Company"), which was confirmed by the United States Bankruptcy Court for the Southern District of New York on August 28, 2013, was consummated. As a result, all issued and outstanding shares of the Companys Class A Common Stock, Class B Common Stock and 7% Cumulative Convertible Preferred Stock, and the warrants and options exercisable therefor, were cancelled and extinguished.
- [F2]The option was to vest in five equal annual installments beginning on September 7, 2011.
- [F3]The option was to vest in five equal installments beginning on June 10, 2011.
- [F4]The option was to vest in three equal installments beginning on September 8, 2012.
- [F5]The option was to vest 33% on May 14, 2013, 33% on May 14, 2014 and 34% on May 14, 2015.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000057055
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 1:52 PM ET
- Size
- 13.9 KB